These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6262246)

  • 1. Lysis of herpes simplex virus-infected cells early in the infectious cycle by human antiviral antibody and complement.
    Cromeans TL; Shore SL
    Infect Immun; 1981 Mar; 31(3):1054-61. PubMed ID: 6262246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts.
    Fitzgerald-Bocarsly P; Howell DM; Pettera L; Tehrani S; Lopez C
    J Virol; 1991 Jun; 65(6):3151-60. PubMed ID: 1709697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of antibody-mediated binding of human polymorphonuclear leukocytes to HSV-1 infected anchorage fibroblasts.
    Van Kessel KP; Van Kats-Renaud HJ; Van Strijp JA; Visser MR; Verhoef J
    J Immunol Methods; 1986 Apr; 88(1):101-7. PubMed ID: 3007623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuraminidase reversal of resistance to lysis of herpes simplex virus-infected cells by antibody and complement.
    Tompkins WA; Seth P; Gee S; Rawls WE
    J Immunol; 1976 Feb; 116(2):489-95. PubMed ID: 175118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of antibodies to Herpes simplex virus types 1 and 2 by complement-dependent antibody lysis of infected cells.
    McClung H; Seth P; Rawls WE
    Am J Epidemiol; 1976 Aug; 104(2):181-91. PubMed ID: 60057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
    Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
    J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratypic and intertypic specificity of lymphocytes involved in the recognition of herpes simplex virus glycoproteins.
    Carter VC; Rice PL; Tevethia SS
    Infect Immun; 1982 Jul; 37(1):116-26. PubMed ID: 6286488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of three major glycoprotein antigens of herpes simplex virus type 1 early in the infectious cycle as determined by antibody-dependent cell-mediated cytotoxicity.
    Norrild B; Shore SL; Cromeans TL; Nahmias AJ
    Infect Immun; 1980 Apr; 28(1):38-44. PubMed ID: 6247286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera.
    Subramanian T; Rawls WE
    J Clin Microbiol; 1977 Jun; 5(6):551-8. PubMed ID: 195975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of human arterial smooth muscle cells infected with herpesviridae by peripheral blood mononuclear cells: implications for atherosclerosis.
    Datta SK; Tumilowicz JJ; Trentin JJ
    Viral Immunol; 1993; 6(2):153-60. PubMed ID: 8216714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of cell-to-cell spread of herpes simplex virus by leukocytes.
    Lodmell DL; Niwa A; Hayashi K; Notkins AL
    J Exp Med; 1973 Mar; 137(3):706-20. PubMed ID: 4347596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-fixing antibody to the AG-4 antigen in herpes simplex virus type 2-infected patients.
    Arsenakis M; May JT
    Infect Immun; 1981 Jul; 33(1):22-8. PubMed ID: 6266964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody mediated destruction of keratocytes infected with herpes simplex virus.
    Sheppard AM; Smith JW
    Curr Eye Res; 1981; 1(7):397-402. PubMed ID: 6274587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.
    Nemerow GR; Jensen FC; Cooper NR
    J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
    Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
    J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of virus-specific antigens in extracts from herpes simplex virus-infected cells by a Cr release inhibition test.
    Kutinová L; Vonka V
    Infect Immun; 1978 Jun; 20(3):587-91. PubMed ID: 78899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
    Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
    J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of recognition of herpes simplex virus type 1-infected cells by natural killer cells.
    López-Guerrero JA; Alarcón B; Fresno M
    J Gen Virol; 1988 Nov; 69 ( Pt 11)():2859-68. PubMed ID: 2846762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.